A Rare Case of Central Diabetes Insipidus in a Pediatric Patient
DOI:
https://doi.org/10.20344/amp.21113Keywords:
Autoimmune Hypophysitis/diagnosis, Child, Diabetes Insipidus, Neurogenic/diagnosis, Pituitary Gland/diagnosisAbstract
N/a.
Downloads
References
Schaefers J, Cools M, De Waele K, Gies I, Beauloye V, Lysy P, et al. Clinical presentation and outcome of children with central diabetes insipidus associated with a self-limited or transient pituitary stalk thickening, diagnosed as infundibuloneurohypophysitis. Clin Endocrinol. 2017;87:171-6.
Morota K, Tadokoro H, Sawano K, Watanabe K, Iwata N, Fujisawa H, et al. A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti-rabphilin-3A antibody positivity. J Pediatr Endocrinol Metab. 2022;35:687-90.
Johnston PC, Chew LS, Hamrahian AH, Kennedy L. Lymphocytic infundibulo-neurohypophysitis: a clinical overview. Endocrine. 2015;50:531-6.
Moszczyńska E, Kunecka K, Baszyńska-Wilk M, Perek-Polnik M, Majak D, Grajkowska W. Pituitary stalk thickening: causes and consequences. the children’s memorial health institute experience and literature review. Front Endocrinol. 2022;13:868558.
Donegan D, Saeed Z, Delivanis DA, Murad MH, Honegger J, Amereller F, et al. Outcomes of initial management strategies in patients with autoimmune lymphocytic hypophysitis: a systematic review and meta- analysis. J Clin Endocrinol Metab. 2022;107:1170-90.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
